V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20177941 | 20066379 | 1.6 | 70 | Neo-adjuvant (N) | 2021-12-02 | 2021-12-03 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101458129 |
| 20177948 | 20066380 | 1.65 | 87.6 | Neo-adjuvant (N) | 2016-07-11 | 2016-07-19 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100712178 |
| 20177949 | 20066381 | 1.84 | 60 | Curative (C) | 2019-09-09 | 2019-09-20 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 100613159 |
| 20177951 | 20066382 | 1.62 | 82.6 | Curative (C) | 2016-06-29 | 2016-07-14 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101686725 |
| 20177953 | 20066383 | 1.69 | 64.2 | Adjuvant (A) | 2019-08-25 | 2019-09-01 | FLUOROURACIL | N | N | FLUOROURACIL | 100770087 |
| 20177955 | 20066384 | 1.78 | 90.8 | Neo-adjuvant (N) | 2020-02-04 | 2020-02-04 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100720356 |
| 20177956 | 20066385 | 1.76 | 72.7 | Adjuvant (A) | 2016-05-05 | 2016-05-19 | Fluorouracil + Folinic Acid Weekly | N | N | FLUOROURACIL | 101572209 |
| 20177964 | 20066386 | 1.67 | 114.9 | Adjuvant (A) | 2017-12-13 | 2017-12-16 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100724667 |
| 20177966 | 20066387 | 1.63 | 96.95 | Neo-adjuvant (N) | 2017-03-21 | 2017-03-26 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101318159 |
| 20177970 | 20066388 | 1.68 | 67.6 | Curative (C) | 2017-09-09 | 2017-09-11 | ECX | 02 | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100984129 |
| 20177971 | 20066389 | 1.58 | 66 | Neo-adjuvant (N) | 2018-01-17 | 2018-01-22 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101406217 |
| 20177981 | 20066390 | 1.55 | 86.4 | Adjuvant (A) | 2017-02-13 | 2017-02-27 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101093828 |
| 20177983 | 20066391 | 1.7 | 70.35 | Palliative (P) | 2018-08-08 | 2018-08-21 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101605607 |
| 20177988 | 20066392 | 1.54 | 92.8 | Neo-adjuvant (N) | 2019-07-08 | 2019-07-21 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101476910 |
| 20177992 | 20066393 | 1.83 | 55.65 | Adjuvant (A) | 2020-07-01 | 2020-07-15 | FLUOROURACIL | 02 | N | FLUOROURACIL | 100280961 |
| 20177995 | 20066394 | 1.78 | 108.4 | Neo-adjuvant (N) | 2017-07-12 | 2017-07-12 | ECX | 02 | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101389252 |
| 20177996 | 20066395 | 1.74 | 84.5 | Curative (C) | 2019-10-04 | 2019-10-10 | FLUOROURACIL | 02 | N | FLUOROURACIL | 101043986 |
| 20177999 | 20066396 | 1.75 | 111 | Neo-adjuvant (N) | 2019-02-14 | 2019-02-21 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100855910 |
| 20178010 | 20066397 | 1.56 | 86.4 | Curative (C) | 2017-12-20 | 2018-01-07 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101055180 |
| 20178012 | 20066398 | 1.73 | 77 | Adjuvant (A) | 2017-08-15 | 2017-08-22 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 100828353 |
| 20178015 | 20066399 | 1.65 | 67.4 | Curative (C) | 2019-10-09 | 2019-10-09 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101284005 |
| 20178018 | 20066400 | 1.63 | 100 | Palliative (P) | 2018-07-05 | 2018-07-13 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101444235 |
| 20178023 | 20066401 | 1.77 | 101.1 | Palliative (P) | 2016-11-19 | 2016-12-01 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100493104 |
| 20178026 | 20066402 | 1.74 | 90 | Palliative (P) | 2019-07-16 | 2019-07-21 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100332059 |
| 20178030 | 20066403 | 1.64 | 70.15 | Adjuvant (A) | null | 2019-02-24 | FLUOROURACIL | N | N | FLUOROURACIL | 101613530 |
| 20178031 | 20066404 | 1.79 | 51.4 | Neo-adjuvant (N) | 2020-01-09 | 2020-01-17 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100694435 |
| 20178033 | 20066405 | 1.7 | 62.9 | Adjuvant (A) | 2017-07-04 | 2017-08-19 | FLUOROURACIL | 02 | N | FLUOROURACIL | 101106644 |
| 20178036 | 20066406 | 1.72 | 84.8 | Palliative (P) | 2020-01-17 | 2020-01-17 | FLUOROURACIL | N | null | FLUOROURACIL | 101216534 |
| 20178037 | 20066407 | 1.57 | 93.4 | Adjuvant (A) | 2017-02-18 | 2017-02-25 | FLUOROURACIL | 02 | N | FLUOROURACIL | 100288307 |
| 20178039 | 20066408 | 1.53 | 51.9 | null | 2018-08-12 | 2018-08-12 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 101739702 |
| 20178040 | 20066409 | null | null | Adjuvant (A) | 2018-10-12 | 2018-11-11 | Fluorouracil + Folinic Acid Weekly | N | N | FLUOROURACIL | 101546315 |
| 20178041 | 20066410 | null | null | Adjuvant (A) | 2019-02-18 | 2019-03-03 | Fluorouricil + Folonic Acid (MdG) | 02 | N | FLUOROURACIL | 101586211 |
| 20178044 | 20066411 | 1.65 | 79.7 | Neo-adjuvant (N) | 2017-09-02 | 2017-09-25 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100506895 |
| 20178047 | 20066412 | 1.62 | 81.1 | Adjuvant (A) | 2017-02-03 | 2017-02-03 | Fluorouracil + Folinic + RT Bossett | 02 | N | FLUOROURACIL | 100813679 |
| 20178053 | 20066413 | 1.52 | 82 | Palliative (P) | 2018-02-19 | 2018-03-03 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101792404 |
| 20178054 | 20066414 | 1.54 | 81.8 | Adjuvant (A) | 2016-11-17 | 2016-12-06 | FLUOROURACIL | 02 | N | FLUOROURACIL | 100432039 |
| 20178060 | 20066415 | 1.75 | 60.7 | Adjuvant (A) | 2017-12-01 | 2017-12-01 | FLUOROURACIL | 02 | N | FLUOROURACIL | 100197875 |
| 20178062 | 20066416 | 1.8 | 88.2 | Adjuvant (A) | 2017-07-23 | 2017-08-12 | Fluorouricil + Folonic Acid (MdG) | N | N | FLUOROURACIL | 100911309 |
| 20178063 | 20066417 | 1.59 | 68 | Palliative (P) | 2019-01-12 | 2019-01-21 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101311317 |
| 20178064 | 20066418 | 1.79 | 87.4 | Neo-adjuvant (N) | 2019-03-30 | 2019-04-19 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 100007171 |
| 20178065 | 20066419 | 1.53 | 77.3 | Adjuvant (A) | 2019-01-29 | 2019-02-18 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 100349930 |
| 20178068 | 20066420 | 1.74 | 75.9 | Adjuvant (A) | 2017-05-20 | 2017-05-20 | Fluouracil continuous infusion | N | null | FLUOROURACIL | 100426474 |
| 20178072 | 20066421 | 1.61 | 104.8 | Adjuvant (A) | 2019-04-20 | 2019-04-20 | Fluorouracil + Folinic Acid Weekly | 02 | null | FLUOROURACIL | 101280203 |
| 20178079 | 20066422 | 1.62 | 84.5 | Neo-adjuvant (N) | 2019-04-10 | 2019-04-10 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101020363 |
| 20178081 | 20066423 | 1.55 | 89 | Curative (C) | 2018-12-26 | 2019-01-06 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100954748 |
| 20178087 | 20066424 | 1.71 | 77 | Palliative (P) | 2019-12-30 | 2020-01-08 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101865867 |
| 20178099 | 20066425 | 1.71 | 76.6 | Palliative (P) | 2019-08-17 | 2019-08-22 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100559845 |
| 20178100 | 20066426 | 1.62 | 116.9 | Neo-adjuvant (N) | 2016-06-16 | 2016-06-30 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100747721 |
| 20178101 | 20066427 | 1.62 | 48.8 | Neo-adjuvant (N) | 2018-03-12 | 2018-03-15 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101463919 |
| 20178115 | 20066428 | 1.7 | 80.9 | Adjuvant (A) | 2018-05-05 | 2018-05-16 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 100413704 |